United States
Germany
Japan
United Kingdom
China
Lenti ORF clone of Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 2, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Expression Plasmids
Lenti ORF clone of Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 2, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP |
- LentiORF®
Lenti ORF clone of Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 1, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 1, mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP |
- LentiORF®
活动过滤器
优化搜索结果
Category
Species
Lentivirus
Mutants
Brands
Families
Pathways
- Acute myeloid leukemia (4)
- Adherens junction (4)
- Alzheimer's disease (4)
- Axon guidance (4)
- B cell receptor signaling pathway (4)
- Bladder cancer (4)
- Chemokine signaling pathway (4)
- Chronic myeloid leukemia (4)
- Colorectal cancer (4)
- Dorso-ventral axis formation (4)
- Endometrial cancer (4)
- ErbB signaling pathway (4)
- Fc epsilon RI signaling pathway (4)
- Fc gamma R-mediated phagocytosis (4)
- Focal adhesion (4)
- Gap junction (4)
- Glioma (4)
- GnRH signaling pathway (4)
- Insulin signaling pathway (4)
- Long-term depression (4)
- Long-term potentiation (4)
- MAPK signaling pathway (4)
- Melanogenesis (4)
- Melanoma (4)
- NOD-like receptor signaling pathway (4)
- Natural killer cell mediated cytotoxicity (4)
- Neurotrophin signaling pathway (4)
- Non-small cell lung cancer (4)
- Oocyte meiosis (4)
- Pancreatic cancer (4)
- Pathways in cancer (4)
- Prion diseases (4)
- Progesterone-mediated oocyte maturation (4)
- Prostate cancer (4)
- Regulation of actin cytoskeleton (4)
- Renal cell carcinoma (4)
- T cell receptor signaling pathway (4)
- TGF-beta signaling pathway (4)
- Thyroid cancer (4)
- Toll-like receptor signaling pathway (4)
- Type II diabetes mellitus (4)
- VEGF signaling pathway (4)
- Vascular smooth muscle contraction (4)
- mTOR signaling pathway (4)
